Overview
Sotyktu is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy, and for the treatment…
Overview
Wynzora is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in people ages 18 and older. Wynzora is a combination drug composed of Calcipotriene and… read more